Renewable Policy Analysis - April, 2013

Renewable Policy Analysis - April, 2013
 
 Summary
 
 The “Renewable Policy Analysis” provides in depth study of the major renewable policy developments across the globe. It gives regulatory and other associated updates for the global renewable energy market which can help the individual/company to frame their business strategies while minimizing regulatory risks. For the April 2013 issue, it covers two featured articles ""European Commission Has Started the Registration of Solar Products from China"" and “Andhra Pradesh Solar Power Policy: Needs More Clarity to Shape Industry in the State"", providing excellent analysis on these development.""
 
 Scope
 
 This report includes policy updates on the major countries. There are key news stories covered in the report, of which following two articles are covered in detail - 
 - Featured Articles: Analytical articles related to the impact of major policies on the renewable energy market.
 - European Commission Has Started the Registration of Solar Products from China.
 - Andhra Pradesh Solar Power Policy: Needs More Clarity to Shape Industry in the State
 
 Reasons to buy
 
 - This renewable policy report includes major policy developments in the renewable energy market for the month of April 2013. The report consists of - 
 - Featured articles: Analytical articles related to the impact of major policies in the renewable energy market.
 - Key news highlights: Key renewable policy news alerts.
 - Major policy updates: Regional renewable policy news.

1.1 List of Tables 1
2 Summary 1
3 Renewable Policy Analysis – April, 2013 1
3.1 European Commission Has Started the Registration of Solar Products from China. 1
3.1.1 Summary 1
3.1.2 European Commission has Started the Registration of Solar Products Imported from China 2
3.1.3 Alliance for Affordable Solar Energy Warns about the Negative Consequences of Countervailing Duties. 2
3.1.4 Implementing Anti-Dumping Duties will Slow Down Solar PV Installation Growth 2
3.1.5 Anti-Dumping Tariff will Save Interest Domestic Manufacturers in a Few Countries, but will Increase the Installation Cost in Others 2
3.2 Andhra Pradesh Solar Power Policy: Needs More Clarity to Shape Industry in the State 2
3.2.1 Comparison to Solar Policies of Other States 3
3.2.2 Industry Reaction to the Solar Policy 3
3.2.3 Objectives of the Solar Power Policy 3
3.2.4 Guidelines for Renewable Energy Certificate Mechanism for Utility Scale Projects 3
3.2.5 Guidelines for Implementation of Net Metering 3
3.2.6 Government Incentives/Guidelines for Projects through Renewable Energy Certificate Mechanism and Net Metering 4
3.3 Key News Highlights – Key Renewable Policy News Alerts of the Month 4
3.3.1 Americas 4
3.3.2 Europe 8
3.3.3 Asia-Pacific 9
4 Appendix 16
4.1 Abbreviations 16
4.2 Methodology 16
4.3 Contact Us 17
4.4 Disclaimer 17

1.1 List of Tables
Table 1: Abbreviations 16

For more information, please visit:

http://www.aarkstore.com/reports/Renewable-Policy-Analysis-April-2013-201145.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Latin America Regional Power Market Outlook to 2030

Latin America Regional Power Market Outlook to 2030
 
 Summary
 
 This report gives detailed information on the Latin American power market. It examines the region’s power market structure and provides historical and forecast numbers for generation, capacity and consumption up to 2030. The report also analyses the power sector of the region on 6 broad parameters which include supply security, regulatory scenario, infrastructure, macroeconomics, competition and future potential of the power sector. Each parameter has a weight assigned, and a weighted average score is calculated to obtain the country ranking in the Latin American region.
 
 Scope
 
 - Analysis of the region’s power sector across six parameters - supply security, regulatory scenario, infrastructure, macroeconomics, competition and future potential of the power sector. 
 - Relative ranking of the country in the region based on the above parameters.
 - Region level Statistics for installed capacity, power generation and consumption from 2000 to 2011, forecast for the next 18 years to 2030. 
 - Break-up by technology, including thermal, hydro, renewable and nuclear 
 - Policy and regulatory framework governing the market. 
 - Detailed analysis of top market participant and including market share analysis. 
 
 Reasons to buy
 
 - Identify opportunities and plan strategies by having a strong understanding of the investment opportunities in the country’s power sector 
 - Identification of key factors driving investment opportunities in the country’s power sector 
 - Facilitate decision-making based on strong historic and forecast data 
 - Develop strategies based on the latest regulatory events 
 - Position yourself to gain the maximum advantage of the industry’s growth potential 
 - Identify key partners and business development avenues 
 - Identify key strengths and weaknesses of important market participants 
 - Respond to your competitors’ business structure, strategy and prospects

1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
3 Latin America Market Analysis, 2000–2030 7
3.1 Latin America, Power Market, Installed Capacity, 2000–2030 7
3.1.1 Installed Capacity: Breakdown by Type of Power Plant, 2012 7
3.1.2 Cumulative Installed Capacity and Annual Generation, 2000–2030 8
3.2 Latin America, Power Market, Annual Power Consumption, 2000–2030 11
3.3 Key Opportunities in Latin American Power Markets 13
3.3.1 Competitive power market and increased private participation 13
3.3.2 Growing focus on increasing renewable energy share 13
3.3.3 Smart grid initiative 13
3.3.4 Increase in electricity trading 13
3.4 Major Challenges in Power Sector of Latin American Markets 14
3.4.1 Excessive dependence on hydropower sources 14
3.4.2 Hurdles in issuance of environmental licenses 14
3.4.3 Reliance on imported natural gas 14
3.4.4 Tight reserve margin 15
3.4.5 Poor T&D Infrastructure leading to high losses 15
4 Power Market Comparison of Latin American Economies 16
4.1 Colombia and Argentina Assure Stable Supply Security 17
4.2 Brazil is the Most Developed Power Market in Latin America 18
4.3 Argentina, Brazil, Chile Boasts of a Highly Competitive Power Market 19
4.4 Peru and Chile Provide Excellent Business Opportunities 19
4.5 Peru and Brazil’s Regulatory Framework Encourages Development in the Power Market 20
4.6 Brazil and Chile Present Strong Future Growth Potential 21
4.7 Conclusion 22
5 Appendix 23
5.1 Latin America, Power Market, Business Propensity Indicator Methodology 23
5.1.1 Supply Security 23
5.1.2 Regulatory Scenario 23
5.1.3 Infrastructure 24
5.1.4 Macroeconomic Scenario 24
5.1.5 Competitive Scenario 26
5.1.6 Future Potential 26
5.2 Methodology Adopted to Arrive at Final Rank 27
5.3 Abbreviations 29
5.4 Bibliography 29
5.5 GlobalData’s Methodology 30
5.5.1 Secondary research and analysis 30
5.5.2 Primary Research and Analysis 31
5.6 Contact Us 31
5.7 Disclaimer 31

1.1 List of Tables
Table 1: Power Market, Latin America, Cumulative Installed Capacity by Type of Power Plant (%), 2012 7
Table 2: Power Market, Latin America, Cumulative Installed Capacity (MW) and Annual Power Generation (GWh), 2000–2030 10
Table 3: Power Market, Latin America, Annual Power Consumption (GWh), 2000–2030 12
Table 4: Power Market, Latin American Countries, Power Supply Security Parameters, 2011 17
Table 5: Power Market, Latin America, Ease of Doing Business (2011) and GDP Growth Rates, 2006–2011 (%) 20
Table 6: Ease of Doing Business-Categories and Definitions 25
Table 7: Country Risk-Categories and Sub-categories 25
Table 8: BPI Scoring Parameters 28
Table 9: Abbreviations 29

1.2 List of Figures
Figure 1: Power Market, Latin American Countries 6
Figure 2: Power Market, Latin American, Cumulative Installed Capacity by Type of Power Plant (%), 2012 7
Figure 3: Power Market, Latin America, Cumulative Installed Capacity (MW) and Annual Power Generation (GWh), 2000–2030 9
Figure 4: Power Market, Latin America, Annual Power Consumption (GWh), 2000–2030 11
Figure 5: Power Market, Latin America, Business Propensity Indicator Ranking, 2011 16
Figure 6: Power Market, Latin America, Electrification Rates and T&D Losses (%), 2011 18
Figure 7: Weights Assigned to the Six Factors (%), 2000-2020 27

For more information, please visit:

http://www.aarkstore.com/reports/Latin-America-Regional-Power-Market-Outlook-to-2030-280672.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Russia Iron Ore Mining Market Overview and Forecast to 2020 - Trends, Major Projects and Competitive Landscape

Russia Iron Ore Mining Market Overview and Forecast to 2020 - Trends, Major Projects and Competitive Landscape
 
 Summary
 
 ""Russia Iron Ore Mining Market Overview and Forecast to 2020 - Trends, Major Projects and Competitive Landscape"" provides a comprehensive understanding of the iron ore mining industry in Russia. This report provides historical and forecast data on iron ore production, consumption and trade (export and/or imports) to 2020. In addition to this, the report also includes drivers and restraints affecting the industry, profiles of major iron ore mining companies and information on major active, planned and exploration mines. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
 
 Scope
 
 - Overview of the Russia iron ore mining industry, with detailed information about production, production by forms, reserves, consumption and trade
 - Historic data from 2000 to 2012, and forecast to 2020
 - Key growth factors and restraints affecting the Russian iron ore mining industry
 - List of major active and planned iron ore mines
 - Profiles of key iron ore mining companies
 
 Reasons to buy
 
 - Gain a strong understanding of the country’s iron ore mining industry
 - Facilitate market analysis and forecasting of future industry trends
 - Facilitate decision making and strategy formulation on the basis of strong historic and forecast production, consumption and trade data.
 - Identify key growth and investment opportunities in the country's iron ore mining industry 
 - Position yourself to gain the maximum advantage of the industry’s growth potential

1.1 List of Tables 4
1.2 List of Figures 4
2 Executive Summary 5
2.1 Iron Ore Production and Consumption to Increase Moderately 5
2.2 Iron Ore Prices to Decrease 5
3 Introduction 6
3.1 GlobalData Report Guidance 6
4 Russia Iron Ore Mining Industry – Drivers and Restraints 7
4.1 Russia Iron Ore Mining Industry – Drivers 7
4.1.1 New Projects and Capacity Additions to Support Iron Ore Production 7
4.1.2 Abundant Iron Ore Reserves 7
4.2 Russia Iron Ore Mining Industry – Restraints 8
4.2.1 Declining Iron Ore Prices 8
4.2.2 Unfavoured Nation 8
5 Russia Iron Ore Mining Industry – Production, Reserves, Consumption and Trade 9
5.1 Russia Iron Ore Mining Industry – Total Production 9
5.1.1 Russia Iron Ore Mining Industry – Total Production by Form 11
5.2 Russia Iron Ore Mining Industry – Total Reserves 15
5.3 Russia Iron Ore Mining Industry – Total Consumption 17
5.4 Russia Iron Ore Mining Industry – Exports and Imports Scenario 19
5.4.1 Russia Iron Ore Mining Industry – Exports by Country of Destination 22
6 Russia Iron Ore Mining Industry – Major Active Projects, Planned Projects and Exploration Projects 24
6.1 Russia Iron Ore Mining Industry – Major Active Projects 24
6.2 Russia Iron Ore Mining Industry – Major Planned Projects and Exploration Projects 24
7 Russia Iron Ore Mining Industry – Competitive Landscape 25
7.1 Russia Iron Ore Mining Industry – Key Companies, OAO Holding Company Metalloinvest 25
7.1.1 OAO Holding Company Metalloinvest, Overview 25
7.1.2 OAO Holding Company Metalloinvest, Business Description 25
7.1.3 OAO Holding Company Metalloinvest, Iron Ore Projects 27
7.2 Russia Iron Ore Mining Industry – Key Companies, OAO Severstal 27
7.2.1 OAO Severstal, Overview 27
7.2.2 OAO Severstal, Business Description 27
7.2.3 OAO Severstal, Iron Ore Projects 28
8 Appendix 29
8.1 Abbreviations 29
8.2 Bibliography 29
8.3 GlobalData’s Methodology 30
8.3.1 Coverage 31
8.3.2 Secondary Research 31
8.3.3 Primary Research 31
8.3.4 Expert Panel Validation 32
8.4 Contact Us 32
8.5 Disclaimer 32

1.1 List of Tables
Table 1: Iron Ore Mining Industry, Russia, Total Production (MMt), 2000–2020 10
Table 2: Iron Ore Mining Industry, Russia, Total Production by Form, Lumps (MMt), 2000–2020 12
Table 3: Iron Ore Mining Industry, Russia, Total Production by Form, Fines (MMt), 2000–2020 14
Table 4: Iron Ore Mining Industry, Russia, Total Reserves (MMt), 2000–2012 16
Table 5: Iron Ore Mining Industry, Russia, Total Consumption (MMt), 2000–2020 18
Table 6: Iron Ore Mining Industry, Russia, Exports/Imports (MMt), 2000–2020 21
Table 7: Iron Ore Mining Industry, Russia, Exports by Region and Country of Destination (MMt), 2012 23
Table 8: Iron Ore Mining Industry, Russia, Major Active Projects 24
Table 9: Iron Ore Mining Industry, Russia, Major Planned Projects and Exploration Projects 24
Table 10: Iron Ore Mining Industry, Russia, OAO Holding Company Metalloinvest, Major Iron Ore Projects 27
Table 11: Iron Ore Mining Industry, Russia, OAO Severstal, Major Iron Ore Projects 28

1.2 List of Figures
Figure 1: Iron Ore Mining Industry, Russia, Production and Exports (MMt), 2000–2020 5
Figure 2: Iron Ore Mining Industry, Russia, Total Production (MMt), 2000–2020 9
Figure 3: Iron Ore Mining Industry, Russia, Total Production by Form, Lumps (MMt), 2000–2020 11
Figure 4: Iron Ore Mining Industry, Russia, Total Production by Form, Fines (MMt), 2000–2020 13
Figure 5: Iron Ore Mining Industry, Russia, Total Reserves (MMt), 2000–2012 15
Figure 6: Iron Ore Mining Industry, Russia, Total Consumption (MMt), 2000–2020 17
Figure 7: Iron Ore Mining Industry, Russia, Total Exports (MMt), 2000–2020 19
Figure 8: Iron Ore Mining Industry, Russia, Total Imports (MMt), 2000–2020 20
Figure 9: Iron Ore Mining Industry, Russia, Exports by Country of Destination (%), 2012# 22

OAO Holding Company Metalloinvest
OAO Severstal

For more information, please visit:

http://www.aarkstore.com/reports/Russia-Iron-Ore-Mining-Market-Overview-and-Forecast-to-2020-Trends-Major-Projects-and-Competitive-Landscape-280673.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Sjogrens Syndrome Global Clinical Trials Review, H1, 2013

Sjogrens Syndrome Global Clinical Trials Review, H1, 2013

Summary

“Sjogren’s Syndrome Global Clinical Trials Review, H1, 2013 provides data on the Sjogren’s Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sjogren’s Syndrome. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sjogren’s Syndrome. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
 

List of Tables 4
List of Figures 5
Introduction 6
Sjogrens Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Sjogrens Syndrome 23
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Sjogrens Syndrome Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Parion Sciences, Inc. 30
Clinical Trial Overview of Parion Sciences, Inc. 30
Alcon Research Ltd. 31
Clinical Trial Overview of Alcon Research Ltd. 31
Controlled Therapeutics Ltd 32
Clinical Trial Overview of Controlled Therapeutics Ltd 32
DENTAID, S.L. 33
Clinical Trial Overview of DENTAID, S.L. 33
Advanced Vision Research, Inc. 34
Clinical Trial Overview of Advanced Vision Research, Inc. 34
Raptor Pharmaceuticals Corp. 35
Clinical Trial Overview of Raptor Pharmaceuticals Corp. 35
Otsuka Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 36
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37

For more information, please visit:

http://www.aarkstore.com/reports/Sjogrens-Syndrome-Global-Clinical-Trials-Review-H1-2013-276885.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2013

Summary
 
 “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2013"" provides data on the Open-Angle Glaucoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Open-Angle Glaucoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Open-Angle Glaucoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
 
 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
 - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
 - Listings of discontinued trials (suspended, withdrawn and terminated)
 
 Reasons to buy
 
 - Understand the dynamics of a particular indication in a condensed manner
 - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
 - Obtain discontinued trial listing for trials across the globe
 - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 4
List of Figures 6
Introduction 7
Open-Angle Glaucoma 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Open-Angle Glaucoma 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Alcon Research Ltd. 33
Clinical Trial Overview of Alcon Research Ltd. 33
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Alcon, Inc. 42
Clinical Trial Overview of Alcon, Inc. 42
Santen Pharmaceutical Co., Ltd. 44
Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 44
Novartis AG 46
Clinical Trial Overview of Novartis AG 46
QLT Inc. 47
Clinical Trial Overview of QLT Inc. 47
Kowa Company, Ltd. 48
Clinical Trial Overview of Kowa Company, Ltd. 48
Glaukos Corporation 49
Clinical Trial Overview of Glaukos Corporation 49
Bausch & Lomb Incorporated 50
Clinical Trial Overview of Bausch & Lomb Incorporated 50
Aerie Pharmaceuticals, Inc. 51
Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 51
Laboratorios Sophia S.A. de C.V. 52
Clinical Trial Overview of Laboratorios Sophia S.A. de C.V. 52
Pharmaceutical Research Network LLC 53
Clinical Trial Overview of Pharmaceutical Research Network LLC 53
Merck & Co., Inc. 54
Clinical Trial Overview of Merck & Co., Inc. 54
VISTAKON Pharmaceuticals, LLC 55
Clinical Trial Overview of VISTAKON Pharmaceuticals, LLC 55
Alcon Laboratories Ltd 56
Clinical Trial Overview of Alcon Laboratories Ltd 56
Aurolab 57
Clinical Trial Overview of Aurolab 57
Sun Pharma Advanced Research Company 58
Clinical Trial Overview of Sun Pharma Advanced Research Company 58
Alfred E. Tiefenbacher (GmbH & Co. KG) 59
Clinical Trial Overview of Alfred E. Tiefenbacher (GmbH & Co. KG) 59
Altheos, Inc. 60
Clinical Trial Overview of Altheos, Inc. 60
Clinical Trial Overview of Top Universities / Institutes / Hospitals 61
Medical University of Vienna 61
Clinical Trial Overview of Medical University of Vienna 61
Aristotle University Of Thessaloniki 62
Clinical Trial Overview of Aristotle University Of Thessaloniki 62
University of California, San Diego 63
Clinical Trial Overview of University of California, San Diego 63
University Hospital Basel 64
Clinical Trial Overview of University Hospital Basel 64
Yonsei University 65

For more information, please visit:
http://www.aarkstore.com/reports/Open-Angle-Glaucoma-Global-Clinical-Trials-Review-H1-2013-216542.html
Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise
Tel : +912227453309
Mobile No:+08149852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com

Sleep Apnea Global Clinical Trials Review, H1, 2013

Sleep Apnea Global Clinical Trials Review, H1, 2013
 
 Summary
 
 “Sleep Apnea Global Clinical Trials Review, H1, 2013"" provides data on the Sleep Apnea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sleep Apnea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sleep Apnea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
 
 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
 - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
 - Listings of discontinued trials (suspended, withdrawn and terminated)
 
 Reasons to buy
 
 - Understand the dynamics of a particular indication in a condensed manner
 - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
 - Obtain discontinued trial listing for trials across the globe
 - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 4
List of Figures 6
Introduction 7
Sleep Apnea 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Sleep Apnea 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Sleep Apnea Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Associacao Fundo de Incentivo a Psicofarmcologia 33
Clinical Trial Overview of Associacao Fundo de Incentivo a Psicofarmcologia 33
Cephalon, Inc. 34
Clinical Trial Overview of Cephalon, Inc. 34
Fisher & Paykel Healthcare, Inc. 35
Clinical Trial Overview of Fisher & Paykel Healthcare, Inc. 35
Cortex Pharmaceuticals, Inc. 36
Clinical Trial Overview of Cortex Pharmaceuticals, Inc. 36
Philips Respironics, Inc. 37
Clinical Trial Overview of Philips Respironics, Inc. 37
Phillips Respironics International Inc. 38
Clinical Trial Overview of Phillips Respironics International Inc. 38
Mitsubishi Tanabe Pharma Corporation 39
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 39
Covidien plc 40
Clinical Trial Overview of Covidien plc 40
BIOPROJET SCR 41
Clinical Trial Overview of BIOPROJET SCR 41
Merck & Co., Inc. 42
Clinical Trial Overview of Merck & Co., Inc. 42
Sanofi 43
Clinical Trial Overview of Sanofi 43
AGIR a dom. 44
Clinical Trial Overview of AGIR a dom. 44
Schering-Plough K.K. 45
Clinical Trial Overview of Schering-Plough K.K. 45
Orphan Medical, Inc. (Inactive) 46
Clinical Trial Overview of Orphan Medical, Inc. (Inactive) 46
West Side ENT, PLLC 47
Clinical Trial Overview of West Side ENT, PLLC 47
ResMed SAS 48
Clinical Trial Overview of ResMed SAS 48
Cleveland Medical Devices, Inc. 49
Clinical Trial Overview of Cleveland Medical Devices, Inc. 49
VIVUS, Inc. 50
Clinical Trial Overview of VIVUS, Inc. 50
Teva Pharmaceutical Industries Limited 51
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 51
Mylan Inc. 52
Clinical Trial Overview of Mylan Inc. 52
Clinical Trial Overview of Top Universities / Institutes / Hospitals 53
Woolcock Institute of Medical Research 53
Clinical Trial Overview of Woolcock Institute of Medical Research 53
Brigham and Women's Hospital 54
Clinical Trial Overview of Brigham and Women's Hospital 54
The University of Hong Kong 55
Clinical Trial Overview of The University of Hong Kong 55
University Hospital, Grenoble 56
Clinical Trial Overview of University Hospital, Grenoble 56
The University of Chicago 57
Clinical Trial Overview of The University of Chicago 57
National Taiwan University Hospital 58
Clinical Trial Overview of National Taiwan University Hospital 58
Institute for Breathing and Sleep 59
Clinical Trial Overview of Institute for Breathing and Sleep 59
University of Wisconsin Madison 60
Clinical Trial Overview of University of Wisconsin Madison 60
Hospital do Servidor Publico Estadual 61
Clinical Trial Overview of Hospital do Servidor Publico Estadual 61
University of Rochester 62
Clinical Trial Overview of University of Rochester 62
Washington University School of Medicine 63
Clinical Trial Overview of Washington University School of Medicine 63
The Ohio State University 64
Clinical Trial Overview of The Ohio State University 64
Assaf-Harofeh Medical Center 65
Clinical Trial Overview of Assaf-Harofeh Medical Center 65
Kyoto University 66
Clinical Trial Overview of Kyoto University 66
University of Zurich 67
Clinical Trial Overview of University of Zurich 67
University of California, San Francisco 68
Clinical Trial Overview of University of California, San Francisco 68
University Health Network 69
Clinical Trial Overview of University Health Network 69
University of Pennsylvania 70
Clinical Trial Overview of University of Pennsylvania 70
MetroHealth Medical Center 71
Clinical Trial Overview of MetroHealth Medical Center 71
University of Michigan 72
Clinical Trial Overview of University of Michigan 72
Five Key Clinical Profiles 73
Appendix 127
Abbreviations 127
Definitions 127
Research Methodology 128
Secondary Research 128
About GlobalData 129
Contact Us 129
Disclaimer 129
Source 130

List of Tables
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Sleep Apnea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 14
Sleep Apnea Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
Sleep Apnea Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Sleep Apnea Therapeutics Clinical Trials, G7 Countries, 2013* 17
Sleep Apnea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Sleep Apnea Therapeutics Clinical Trials, E7 Countries, 2013* 19
Sleep Apnea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Sleep Apnea Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Sleep Apnea Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Sleep Apnea Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Sleep Apnea Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
Sleep Apnea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Associacao Fundo de Incentivo a Psicofarmcologia, 2013* 33
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2013* 34
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Fisher & Paykel Healthcare, Inc., 2013* 35
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Cortex Pharmaceuticals, Inc., 2013* 36
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Philips Respironics, Inc., 2013* 37
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Phillips Respironics International Inc., 2013* 38
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2013* 39
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Covidien plc, 2013* 40
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET SCR, 2013* 41
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 42
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 43
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by AGIR a dom., 2013* 44
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough K.K., 2013* 45
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Medical, Inc. (Inactive), 2013* 46
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by West Side ENT, PLLC, 2013* 47
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by ResMed SAS, 2013* 48
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Cleveland Medical Devices, Inc., 2013* 49
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by VIVUS, Inc., 2013* 50
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 51
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2013* 52
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Woolcock Institute of Medical Research, 2013* 53
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2013* 54
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2013* 55
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Grenoble, 2013* 56
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 57
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 58
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute for Breathing and Sleep, 2013* 59
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2013* 60
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital do Servidor Publico Estadual, 2013* 61
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2013* 62
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2013* 63
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013* 64
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2013* 65
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 66
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013* 67
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 68
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013* 69
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 70
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by MetroHealth Medical Center, 2013* 71
Sleep Apnea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2013* 72" "List of Figures
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Sleep Apnea Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Sleep Apnea Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Sleep Apnea Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Sleep Apnea Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Sleep Apnea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 14
Sleep Apnea Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Sleep Apnea Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Sleep Apnea Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Sleep Apnea Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Sleep Apnea Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Sleep Apnea Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Sleep Apnea Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Sleep Apnea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
Sleep Apnea Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Sleep Apnea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Sleep Apnea Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 128

For more information, please visit:

http://www.aarkstore.com/reports/Marubeni-to-Acquire-49-Interest-in-Gulfstar-One-from-Williams-Partners-Part-of-Marubeni’s-Plan-to-Boost-its-Presence-in-Oil-and-Gas-Infrastructure-Projects-Deal-Analysis-from-GlobalData-276882.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com

Malaria Global Clinical Trials Review, H1, 2013

Malaria Global Clinical Trials Review, H1, 2013
 
 Summary
 
 “Malaria Global Clinical Trials Review, H1, 2013"" provides data on the Malaria clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malaria. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malaria. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
 
 Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 
 Scope
 
 - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
 - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
 - Listings of discontinued trials (suspended, withdrawn and terminated)
 
 Reasons to buy
 
 - Understand the dynamics of a particular indication in a condensed manner
 - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
 - Obtain discontinued trial listing for trials across the globe
 - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

List of Tables 5
List of Figures 6
Introduction 7
Malaria 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Malaria 24
Subjects Recruited Over a Period of Time 29
Prominent Sponsors 30
Top Companies Participating in Malaria Therapeutics Clinical Trials 32
Prominent Drug Comparison 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
GlaxoSmithKline plc 35
Clinical Trial Overview of GlaxoSmithKline plc 35
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Sanofi 39
Clinical Trial Overview of Sanofi 39
Novartis AG 40
Clinical Trial Overview of Novartis AG 40
Epicentre Biotechnologies 41
Clinical Trial Overview of Epicentre Biotechnologies 41
DBL - Centre for Health Research and Development 42
Clinical Trial Overview of DBL - Centre for Health Research and Development 42
Sanaria Inc. 43
Clinical Trial Overview of Sanaria Inc. 43
Sigma-Tau S.p.A. 44
Clinical Trial Overview of Sigma-Tau S.p.A. 44
Ranbaxy Laboratories Limited 45
Clinical Trial Overview of Ranbaxy Laboratories Limited 45
IPCA Laboratories Limited 46
Clinical Trial Overview of IPCA Laboratories Limited 46
Medecins Sans Frontieres 47
Clinical Trial Overview of Medecins Sans Frontieres 47
Jomaa Pharma GmbH 48
Clinical Trial Overview of Jomaa Pharma GmbH 48
Mutual Pharmaceutical Company, Inc. 49
Clinical Trial Overview of Mutual Pharmaceutical Company, Inc. 49
Novartis Pharmaceuticals Corporation 50
Clinical Trial Overview of Novartis Pharmaceuticals Corporation 50
Dafra Pharma International Ltd. 51
Clinical Trial Overview of Dafra Pharma International Ltd. 51
Proto Pharma Pvt. Ltd. 52
Clinical Trial Overview of Proto Pharma Pvt. Ltd. 52
Vac4All 53
Clinical Trial Overview of Vac4All 53
Dilaforette AB 54
Clinical Trial Overview of Dilaforette AB 54
Sigma-Tau Pharmaceuticals, Inc. 55
Clinical Trial Overview of Sigma-Tau Pharmaceuticals, Inc. 55
RTI International 56
Clinical Trial Overview of RTI International 56
Clinical Trial Overview of Top Universities / Institutes / Hospitals 57
University of Oxford 57
Clinical Trial Overview of University of Oxford 57
Gates Malaria Partnership 61
Clinical Trial Overview of Gates Malaria Partnership 61
London School of Hygiene & Tropical Medicine 63
Clinical Trial Overview of London School of Hygiene & Tropical Medicine 63
U.S. Centers for Disease Control and Prevention 65
Clinical Trial Overview of U.S. Centers for Disease Control and Prevention 65
Radboud University 67
Clinical Trial Overview of Radboud University 67
Institute of Tropical Medicine 68
Clinical Trial Overview of Institute of Tropical Medicine 68
University of California, San Francisco 69
Clinical Trial Overview of University of California, San Francisco 69
Makerere University 70
Clinical Trial Overview of Makerere University 70
Bandim Health Project 71
Clinical Trial Overview of Bandim Health Project 71
University of Heidelberg 72
Clinical Trial Overview of University of Heidelberg 72
Liverpool School of Tropical Medicine 73
Clinical Trial Overview of Liverpool School of Tropical Medicine 73
Hopital Albert Schweitzer 74
Clinical Trial Overview of Hopital Albert Schweitzer 74
University of Cape Town 75
Clinical Trial Overview of University of Cape Town 75
Menzies School of Health Research 76
Clinical Trial Overview of Menzies School of Health Research 76
Centre Muraz 77
Clinical Trial Overview of Centre Muraz 77
Institut de Recherche pour le Developpement 78
Clinical Trial Overview of Institut de Recherche pour le Developpement 78
Queensland Institute of Medical Research 79
Clinical Trial Overview of Queensland Institute of Medical Research 79
Malaria Vaccine and Drug Development Center 80
Clinical Trial Overview of Malaria Vaccine and Drug Development Center 80
Hospital Clinic de Barcelona 81
Clinical Trial Overview of Hospital Clinic de Barcelona 81
Medical University of Vienna 82
Clinical Trial Overview of Medical University of Vienna 82
Five Key Clinical Profiles 83
Appendix 117
Abbreviations 117
Definitions 117
Research Methodology 118
Secondary Research 118
About GlobalData 119
Contact Us 119
Disclaimer 119
Source 120

List of Tables
Malaria Therapeutics Market, Global, Clinical Trials by Zone, 2013* 8
Malaria Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Malaria Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 11
Malaria Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 12
Malaria Therapeutics Clinical Trials, North America, Top Countries, 2013* 13
Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2013* 14
Malaria Therapeutics Clinical Trials, Central and South America, Top Countries, 2013* 15
Malaria Therapeutics Clinical Trials, BRIC Countries, 2013* 16
Malaria Therapeutics Clinical Trials, G7 Countries, 2013* 17
Malaria Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Malaria Therapeutics Clinical Trials, E7 Countries, 2013* 19
Malaria Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Malaria Therapeutics Market, Global, Clinical Trials by Phase, 2013* 21
Malaria Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 22
Malaria Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Malaria Therapeutics Market, Global, Suspended Clinical Trials, 2013* 24
Malaria Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
Malaria Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31
Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33
Malaria Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013* 35
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 37
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 39
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 40
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Epicentre Biotechnologies, 2013* 41
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by DBL - Centre for Health Research and Development, 2013* 42
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanaria Inc., 2013* 43
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau S.p.A., 2013* 44
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Ranbaxy Laboratories Limited, 2013* 45
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by IPCA Laboratories Limited, 2013* 46
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Medecins Sans Frontieres, 2013* 47
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Jomaa Pharma GmbH, 2013* 48
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Mutual Pharmaceutical Company, Inc., 2013* 49
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis Pharmaceuticals Corporation, 2013* 50
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Dafra Pharma International Ltd., 2013* 51
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Proto Pharma Pvt. Ltd., 2013* 52
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Vac4All, 2013* 53
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Dilaforette AB, 2013* 54
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Sigma-Tau Pharmaceuticals, Inc., 2013* 55
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2013* 56
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oxford, 2013* 57
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Gates Malaria Partnership, 2013* 61
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by London School of Hygiene & Tropical Medicine, 2013* 63
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Centers for Disease Control and Prevention, 2013* 65
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 67
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Tropical Medicine, 2013* 68
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 69
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Makerere University, 2013* 70
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Bandim Health Project, 2013* 71
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2013* 72
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Liverpool School of Tropical Medicine, 2013* 73
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital Albert Schweitzer, 2013* 74
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2013* 75
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Menzies School of Health Research, 2013* 76
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Muraz, 2013* 77
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherche pour le Developpement, 2013* 78
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Queensland Institute of Medical Research, 2013* 79
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Malaria Vaccine and Drug Development Center, 2013* 80
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Clinic de Barcelona, 2013* 81
Malaria Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013* 82" "List of Figures
Malaria Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 8
Malaria Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 9
Malaria Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 10
Malaria Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 11
Malaria Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 12
Malaria Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 13
Malaria Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2013* 14
Malaria Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2013* 15
Malaria Therapeutics Clinical Trials, BRIC Countries (%), 2013* 16
Malaria Therapeutics Clinical Trials, G7 Countries (%), 2013* 17
Malaria Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 18
Malaria Therapeutics Clinical Trials, E7 Countries (%), 2013* 19
Malaria Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 20
Malaria Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 21
Malaria Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 22
Malaria Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 23
Malaria Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29
Malaria Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30
Malaria Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32
Malaria Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34
GlobalData Methodology 118

For more information, please visit:

http://www.aarkstore.com/reports/Malaria-Global-Clinical-Trials-Review-H1-2013-155509.html

Or email us at contact@aarkstore.com or call +919272852585

Aarkstore Enterprise

Tel : +912227453309

Mobile No:+08149852585

Email : contact@aarkstore.com

Website : http://www.aarkstore.com